Skip to content

Surgical Trial in Lobar Intracerebral Haemorrhage

Surgical Trial in Lobar Intracerebral Haemorrhage

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01320423
Enrollment
600
Registered
2011-03-22
Start date
2010-08-31
Completion date
2011-08-31
Last updated
2011-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Haemorrhage

Keywords

Intracerebral Haemorrhage

Brief summary

To establish whether a policy of earlier surgical evacuation of the haematoma in selected patients with spontaneous lobar ICH will improve outcome compared to a policy of initial conservative treatment. The trial will also help to better define the indications for early surgery. This will overcome two of the criticisms of STICH (timing was too late and sometimes location was too deep). The subgroup identified in STICH is clinically sensible and the hypothesis identified for STICH II is in line with current neurosurgical opinion.

Detailed description

STICH II is an international multicentre randomised parallel group trial comparing early craniotomy to evacuate the haematoma with initial conservative treatment, following spontaneous superficial intracerebral haemorrhage affecting the lobar region only. Only patients for whom the treating neurosurgeon is in equipoise about the benefits of early craniotomy compared to initial conservative treatment are eligible for the trial. Outcome is measured at six months via a postal questionnaire including the Glasgow Outcome scale, Modified Rankin Scale, EuroQol and Barthel. Six hundred patients will be recruited to the trial over thirty months. Follow-up will take six months with analysis and reporting taking one year.

Interventions

PROCEDURESurgical Trial

Surgical Trial in Lobar Intracerebral Haemorrhage

Sponsors

Taipei Medical University WanFang Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Evidence of a spontaneous lobar ICH on CT scan (1 cm or less from the cortex surface of the brain) * Patient within 48 hours of ictus * Best MOTOR score on the GCS of 5 or 6 and best EYE score on the GCS of 2 or more. * Volume of haematoma between 10 and 100ml \[Calculated using (a x b x c)/2 method\]

Exclusion criteria

* Clear evidence that the haemorrhage is due to an aneurysm or angiographically proven arteriovenous malformation. * Intraventricular haemorrhage of any sort * ICH secondary to tumour or trauma. * Basal ganglia, thalamic, cerebellar or brainstem haemorrhage or extension of a lobar haemorrhage into any of these regions. * Severe pre-existing physical or mental disability or severe co-morbidity which might interfere with assessment of outcome. * If surgery cannot be performed within 12 hours. * If the haematological effects of any previous anticoagulants are not completely reversed.

Design outcomes

Primary

MeasureTime frameDescription
Glasgow Outcome Scale/ Modified Rankin Scalesix monthsUnfavourable outcome will be death or severe disability which will be defined using a prognosis based 8 point Glasgow Outcome Scale/ Modified Rankin Scale

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026